GE Healthcare S.R.L.
- V08 - Medios de contraste
- OMNIPAQUE solution for injection 518 mg (240 mg I)/ml
- VISIPAQUE solution for injection 305 mg(150 mg I)/ml
- VISIPAQUE solution for injection 550 mg(270 mg I)/ml
- VISIPAQUE solution for injection 652 mg(320 mg I)/ml
- V09 - Radiofármacos para diagnóstico
- ADREVIEW solution for injection 74 MBq/ml
- CERETEC kit for radiopharmaceutical preparation 0.5 mg
- IOBENGUANO [131 I] GE HEALTHCARE D solution for injection 9.25 MBq/ml
- MYOVIEW powder for solution for injection 0.23 mg
- SEHCAT capsule, hard 370 kBq
- SODIACAP capsule, hard 0.333 MBq
- SODIACAP capsule, hard 0.592 MBq
- SODIACAP capsule, hard 1.11 MBq
- SODIACAP capsule, hard 2.035 MBq
- SODIACAP capsule, hard 3.7 MBq
- SODIO IODURO 123 I GE HEALTHCARE capsule, hard 18.5 MBq
- SODIO IODURO 123 I GE HEALTHCARE capsule, hard 3.7 MBq
- SODIO IODURO 123 I GE HEALTHCARE capsule, hard 7.4 MBq
- SODIO IODURO 131 I GE HEALTHCARE solution for injection 74 MBq/ ml
- SODIO IODURO 131 I GE HEALTHCARE solution for injection 925 MBq/ ml
- SODIO IODURO 131 I GE oral solution 74 MBq/ ml
- SODIO IODURO 131 I GE oral solution 925 MBq/ ml
- V10 - Radiofármacos terapéuticos
- IOBENGUANO [131 I] GE HEALTHCARE T solution for infusion 185 MBq/ml
- IOBENGUANO [131 I] GE HEALTHCARE T solution for infusion 246.7 MBq/ml
- IOBENGUANO [131 I] GE HEALTHCARE T solution for infusion 493.3 MBq/ml
- THERACAP capsule, hard 37-5.550 MBq